European Archives - Page 1039 of 1232 - European Medical Journal

Novel Chronic Tibial Neuromodulation Treatment Option for Overactive Bladder Significantly Improves Urgency/Urge Urinary Incontinence and Normalises Sleep Patterns: Initial Results

According to the European Association of Urology (EAU), 20–≥30% of adults experience urinary incontinence, while up to an estimated 30% of females aged…

Preventing Urethral Trauma from Inadvertent Inflation of Catheter Balloon in the Urethra During Catheterisation: Evaluation of a Novel Safety Syringe after Correlating Trauma with Urethral Distension and Catheter Balloon Pressure

Urethral catheterisation is a routine task that is frequently performed within a healthcare setting. Urethral injury typically occurs in men when the catheter’s anchoring balloon is inadvertently inflated inside the urethra.

Psychological Distress in Patients Undergoing Surgery for Urological Cancer: A Single-Centre Cross-Sectional Study

There has been increasing interest in the literature on the disease-specific psychological wellbeing of patients with cancer, and it has been estimated…

Relvar Ellipta Significantly Improved Asthma Control in Salford Lung Study Patients Compared with Their Usual Care

GlaxoSmithKline plc and Innoviva Inc today announced positive results from the innovative Salford Lung Study (SLS) in asthma.

Osimertinib Improves Symptoms in Advanced Lung Cancer Patients

Osimertinib improves cancer-related symptoms in patients with advanced lung cancer, according to an analysis presented at the ELCC.

White Blood Cell Count Predicts Response to Lung Cancer Immunotherapy

Geneva, Switzerland, 05 May 2017 – White blood cell counts can predict whether or not lung cancer patients will benefit from immunotherapy, according to…

AlzProtect : The American Food and Drug Administration (FDA) Has Granted AZP2006 the Orphan Drug Designation for the Treatment of Progressive Supranuclear Palsy (PSP)

The American Food and Drug Administration (FDA) has granted AZP2006 the Orphan Drug Designation for the Treatment of Progressive Supranuclear Palsy (PSP)

Hookipa Biotech Presents Positive Data from Phase 1 First-In-Human Trial of Vaccine Against Cytomegalovirus

Vienna, Austria, 04 May, 2017 – Hookipa Biotech AG, a company pioneering a new class of immunotherapies for oncology and infectious diseases, today…

European Commission Extends Approval for Janssen’s DARZALEX®▼(daratumumab) to Include Multiple Myeloma Patients Who Have Received at Least One Prior Therapy

Beerse, Belgium, 28 April, 2017 – Janssen-Cilag International NV (“Janssen”) today announced that the European Commission (EC) has granted approval to…

Single Injection ‘Could Repair Damaged Hearts’ After World-First Trial

Professor Noel Caplice, Chair of Cardiovascular Sciences at University College Cork (UCC), and his cardiologist colleagues at Cork University Hospital…